ÂĄYa disponible! InvestigaciĂłn de Telegram 2025 â los principales insights del aĂąo 
đ¤Always In Greenđ¤
Ir al canal en Telegram
Disclaimer, We are not SEBI registered. The calls given here are Our views and is for educational purposes only, Trading or investing in Market is a high risk activity. Any action you choose to take in the markets is totally your own responsibility !
Mostrar mĂĄs1 040
Suscriptores
Sin datos24 horas
Sin datos7 dĂas
+4230 dĂas
Carga de datos en curso...
Canales Similares
Nube de Etiquetas
Menciones Entrantes y Salientes
---
---
---
---
---
---
Atraer Suscriptores
junio '26
junio '26
+16
en 0 canales
mayo '26
+89
en 0 canales
Get PRO
abril '26
+30
en 0 canales
Get PRO
marzo '26
+17
en 0 canales
Get PRO
febrero '26
+67
en 0 canales
Get PRO
enero '26
+24
en 0 canales
Get PRO
diciembre '25
+9
en 0 canales
Get PRO
noviembre '25
+9
en 0 canales
Get PRO
octubre '25
+12
en 0 canales
Get PRO
septiembre '25
+24
en 0 canales
Get PRO
agosto '25
+27
en 0 canales
Get PRO
julio '25
+36
en 0 canales
Get PRO
junio '25
+44
en 0 canales
Get PRO
mayo '25
+56
en 2 canales
Get PRO
abril '25
+48
en 1 canales
Get PRO
marzo '25
+32
en 0 canales
Get PRO
febrero '25
+22
en 0 canales
Get PRO
enero '25
+53
en 0 canales
Get PRO
diciembre '24
+64
en 1 canales
Get PRO
noviembre '24
+46
en 1 canales
Get PRO
octubre '24
+50
en 1 canales
Get PRO
septiembre '24
+52
en 0 canales
Get PRO
agosto '24
+83
en 1 canales
Get PRO
julio '24
+72
en 2 canales
Get PRO
junio '24
+31
en 1 canales
Get PRO
mayo '24
+34
en 1 canales
Get PRO
abril '24
+22
en 1 canales
Get PRO
marzo '24
+32
en 2 canales
Get PRO
febrero '24
+89
en 2 canales
Get PRO
enero '24
+149
en 2 canales
Get PRO
diciembre '23
+119
en 2 canales
Get PRO
noviembre '23
+37
en 1 canales
Get PRO
octubre '23
+29
en 1 canales
Get PRO
septiembre '23
+7
en 0 canales
Get PRO
agosto '23
+7
en 0 canales
Get PRO
julio '23
+9
en 0 canales
Get PRO
junio '23
+11
en 0 canales
Get PRO
mayo '23
+8
en 0 canales
Get PRO
abril '23
+3
en 0 canales
Get PRO
marzo '23
+1
en 0 canales
Get PRO
febrero '230
en 0 canales
Get PRO
enero '23
+3
en 0 canales
Get PRO
diciembre '22
+11
en 0 canales
Get PRO
noviembre '22
+21
en 0 canales
Get PRO
octubre '22
+6
en 0 canales
Get PRO
septiembre '22
+15
en 0 canales
Get PRO
agosto '22
+17
en 0 canales
Get PRO
julio '22
+10
en 0 canales
Get PRO
junio '22
+3
en 0 canales
Get PRO
mayo '22
+77
en 0 canales
Get PRO
abril '220
en 0 canales
Get PRO
marzo '220
en 0 canales
Get PRO
febrero '220
en 0 canales
Get PRO
enero '220
en 0 canales
Get PRO
diciembre '210
en 0 canales
Get PRO
noviembre '210
en 0 canales
Get PRO
octubre '210
en 0 canales
Get PRO
septiembre '210
en 0 canales
Get PRO
agosto '210
en 0 canales
Get PRO
julio '210
en 0 canales
Get PRO
junio '210
en 0 canales
Get PRO
mayo '21
+191
en 0 canales
| Fecha | Crecimiento de Suscriptores | Menciones | Canales | |
| 13 junio | +3 | |||
| 12 junio | 0 | |||
| 11 junio | 0 | |||
| 10 junio | +1 | |||
| 09 junio | +1 | |||
| 08 junio | 0 | |||
| 07 junio | +3 | |||
| 06 junio | +2 | |||
| 05 junio | +2 | |||
| 04 junio | +1 | |||
| 03 junio | +1 | |||
| 02 junio | 0 | |||
| 01 junio | +2 |
Publicaciones del Canal
ISRO / Space Parts Theme Stocks in India!đ
1.MTAR Technologies
Precision components for space, defence and nuclear sectors.
2 .Data Patterns
Defence and space electronics, radar and avionics systems.
3.L&T
Works on launch vehicle structures, defence and aerospace engineering.
4.HAL
Aerospace manufacturing and satellite/space-related structures.
5.Bharat Electronics
Space and defence electronics, communication and radar systems.
6.Paras Defence
Defence optics, space optics and electronic systems.
7.Centum Electronics
Electronics systems for defence, aerospace and space applications.
8.Avantel
Satellite communication and defence communication systems.
9.Astra Microwave
Radar, RF and microwave systems for defence and space.
10.Taneja Aerospace
Aerospace manufacturing and aircraft component theme.
| 2 | JSWEnergy signs agreement with Kolahai Infotech & SFI Parcel Services to acquire 100% equity shares of Maruti Clean Coal & Power, which owns & nd operates a 300MW thermal power project in the State of Chhattisgarh for Rs. 1,410 cr | 87 |
| 3 | IRAN SAYS BLAST NEAR SIRIK PORT WAS CAUSED BY WARNING SHOTS FIRED AT RULE-BREAKING VESSELS
HORMOZGAN GOVERNOR: EXPLOSION SOUND NEAR SIRIK PORT LINKED TO WARNING FIRE IN STRAIT OF HORMUZ | 87 |
| 4 | Hexaware Opens GIFT City Delivery Centre
- New delivery centre inaugurated
- Located in GIFT City
- Expands Gujarat presence
- Strengthens global delivery network
Focus Areas
- Digital solutions
- Artificial intelligence services
- Cloud transformation
- Data engineering
- Next-generation software services
Client Focus
- Banking sector clients
- Financial services clients
- Insurance industry clients
- Global BFSI opportunities
Expansion Impact
- Around 1,000 jobs planned
- Hiring over next three years
- Enhances innovation capabilities
- Expands technology footprint
Strategic Significance
- Closer to global customers
- Leverages Indian talent pool
- Strengthens delivery capabilities
Key Takeaway
- Supports Hexaware's BFSI growth strategy
- Expands AI and cloud capabilities
- Positive for long-term service expansion | 86 |
| 5 | M&B Engineering: Promoter Buying Watch
Promoter Purchases
- Multiple family members accumulated
- Buying spread across Feb-Jun 2026
- Around 74,000 shares purchased
- Total value about âš2.4 Cr
Purchase Range
- Bought between âš275-354
- Purchases made at higher levels
- Accumulation continued over months
Why It Matters
- Broad-based promoter participation
- Not a single isolated purchase
- Fresh capital committed internally
- Indicates long-term confidence
Key Observation
- Promoters typically possess deeper
operational visibility
- Sustained open-market buying often
reflects positive business outlook
- Multi-member participation strengthens
the signal quality
What To Monitor
- Future promoter purchases
- Business performance trends
- Order inflows and execution
- Margin and cash-flow trajectory
Key Takeaway
- The significance is not the size of the purchases alone, but the fact that multiple promoter-family members have consistently accumulated shares over several months, indicating confidence in the company's long-term prospects. | 68 |
| 6 | Dixon ⢠Optiemus ⢠Amber: DRAM Cost Headwind
- DRAM prices up sharply
- DDR4 and DDR5 surge
- Prices up 250-300% YoY
- AI demand absorbing supply
Industry Dynamics
- Capacity shifting to HBM
- Server memory prioritized
- Consumer memory constrained
- Supply-demand imbalance persists
Potential Impact
- Higher component costs
- Margin pressure risk
- Working capital requirements rise
- Pricing pass-through critical
Stocks To Watch
- Dixon Technologies
- Optiemus Infracom
- Amber Enterprises
Key Takeaway
- Rising memory prices could pressure margins for electronics manufacturers unless higher costs are passed on to customers. | 54 |
| 7 | Affle To Acquire AdColony Assets
- Deal value $4.7 Mn
- Around âš40 Cr acquisition
- Assets acquired from Digital Turbine
- Cash consideration upfront
Assets Included
- iOS and Android SDKs
- Technology platform
- Publisher integrations
- AdColony brand assets
- Domain and goodwill
Strategic Benefits
- Expands publisher network
- Strengthens ad-tech ecosystem
- Improves audience intelligence
- Enhances advertiser conversions
Key Takeaway
- Strategic global acquisition
- Expands mobile advertising capabilities
- Positive for platform scale | 51 |
| 8 | Invicta Diagnostic Expands Subsidiary Network
- New LLP incorporated
- Named Porteus Pathogenius LLP
- Step-down subsidiary created
- Initial capital âš1 Lakh
- Porteus Medical holds 51%
- Agreement signed June 12
Business Focus
- Diagnostics services
- Pathology services
- Laboratory operations
- Allied healthcare services
Key Takeaway
- Expands healthcare footprint
- Supports diagnostics growth strategy
- Strengthens group structure | 53 |
| 9 | Trading will not make you rich.
At least not next week, month, or year.
đťđťđť
But if you don't give up, protect your capital, and
compound your returns you will make it... | 85 |
| 10 | âď¸ WOCKHARDT LTD | Concall Summary+Presentation
â
First Indian Company To Get US FDA Approval For An Indian-Discovered Antibiotic
Zaynich (Cefepime + Zidebactam) received US FDA approval.
A landmark achievement for Indian pharmaceutical innovation.
Management called it a historic moment for both Wockhardt and India.
â
R&D Monetization Phase Has Finally Started
Chairman's key statement:
"For many years investors asked when research investment would translate into growth. We believe that moment has arrived."
Perhaps the most important message from the entire conference.
â
$3-4 Billion Emerging Market Opportunity
Management estimates:
⢠~1.5 Million Carbapenem Resistant (CR) cases annually
⢠Resistance rates of 10%-40% across key emerging markets
⢠$3-4 Billion addressable opportunity
A very large unmet medical need.
â
Covers ~95% Of Carbapenem Resistant Cases In US
Management highlighted that Zaynich's approved breakpoints cover nearly 95% of carbapenem-resistant infections in the US.
A significant competitive advantage.
â
Clinical Results Better Than Meropenem
Phase 3 Study:
⢠96.8% Composite Cure Rate
⢠~20% Superior To Meropenem
The company repeatedly highlighted the strong microbiological cure rates, indicating deeper bacterial eradication and potentially lower hospital readmissions.
â
Massive US Market Opportunity
US Gram-Negative Infection Market:
⢠1.2 Million+ hospital infection cases annually
Including:
⢠cUTI
⢠Hospital Acquired Pneumonia
⢠Bloodstream Infections
⢠Intra-Abdominal Infections
Management believes current approval is only the starting point.
â
Elite US Commercial Team Hired
The newly recruited leadership team has previously launched:
⢠Fetroja
⢠Zerbaxa
⢠Dificid
⢠Xerava
⢠Sivextro
⢠Daptomycin
Strong commercial execution capability has already been assembled.
â
Asset-Light US Launch Model
Instead of building a large fixed-cost organization, Wockhardt is using a partner-led operational model.
Management retains:
⢠Strategy
⢠Medical Affairs
⢠Market Access
While execution infrastructure is outsourced.
Potentially lowers launch risk.
â
India Launch Will Focus On Access
Unlike many innovative drugs that enter India years later:
Wockhardt plans parallel launch strategy.
Management repeatedly emphasized:
"Price should not become a barrier."
Focus areas:
⢠Private Hospitals
⢠Government Hospitals
⢠Patient Access Programs
⢠Real World Evidence
A highly aggressive adoption strategy.
â
India Has Huge Resistance Burden
Estimated annually:
⢠6-7 Lakh Gram-Negative Infection Patients
⢠35%-45% Carbapenem Resistance Burden
Exactly the segment where Zaynich is targeted.
â
Emerging Market Rollout Planned
Over the next 18-24 months, management plans launches across:
⢠Latin America
⢠GCC
⢠Eurasia
⢠South Asia
⢠Southeast Asia
India will serve as the launch blueprint.
â
Biosimilar Business Becoming A Second Growth Engine
Current Diabetes Biosimilar Portfolio:
Commercialized:
⢠Human Insulin
⢠Glargine
Pipeline:
⢠Aspart
⢠RN 30/70
⢠Degludec
⢠Degludec Aspart
⢠Semaglutide
Management estimates a $7-8 Billion diabetes biosimilar opportunity.
â
Financial Position Has Improved Dramatically
FY26 Performance:
Revenue: âš3,373 Cr
EBITDA: âš630 Cr
EBITDA Margin:
5.4% â 18.6% in 3 years
Cash:
âš662 Cr
Net Debt/Equity:
0.1x
The balance sheet is no longer the concern it once was.
â
UK Subscription Model Could Create Recurring Revenue
UK government antibiotic model:
Potential payment:
Up to ÂŁ20 Million annually
Payment is subscription-based rather than volume-based.
Could become a high-margin annuity-like revenue stream.
â
Management Expects "Hockey Stick" Growth
One of the most important Q&A disclosures.
Chairman indicated:
⢠First 12-18 months may see gradual adoption
⢠Significant acceleration expected thereafter
Management explicitly used the analogy of a "Hockey Stick" revenue curve.
Concall PDF | 91 |
| 11 |  đ The upcoming SpaceX IPO could become one of the largest wealth-creation and liquidity events in modern market history.
The reported issue size is around $75 billion.
That means demand could be approaching $300 billion â a figure larger than the entire stock market capitalization of many countries.
But perhaps the most fascinating story is happening inside SpaceX itself.
1000s of employees who joined the company years ago are now set to see the rewards of that journey. Estimates suggest more than 4,400 current and former employees could become dollar millionaires.
Even more striking, hundreds of employees may hold equity worth over $100 million.
For perspective:
â
A $300 billion demand figure is larger than the GDP of several nations.
â
The number of employee millionaires created could exceed the population of many small towns.
â
SpaceX has gone from a startup burning cash to creating one of the largest employee wealth events Silicon Valley has ever witnessed. | 88 |
| 12 |  Only one Pre Engineered Building (Epack Prefab) has guided to grow 30%+ in FY27 - thanks to timely capex
Interarch Building will see a consolidation year
Source: Tar | 82 |
| 13 |  âĄď¸ India's Power Consumption Rises 7% YoY to 138.39 billion units in December 2025.
đĄ Growth driven by higher industrial and commercial activity, along with seasonal demand, indicating steady momentum in the economy, highlights the need for continued investments in power generation capacity and grid infrastructure.
âđť We are tracking Rajesh Power, Oriana Power and Quality Power, specifically focusing on the Power - Renewable(Solar), T&D space.
đŤ No Recommendation. DYODD. | 108 |
| 14 |  Hitachi Energy India will invest approximately âš2000 crore to establish a new Large Power Transformer factory in Vadodara, Gujarat, aiming for completion by FY28. | 107 |
| 15 |  âĄď¸ Hitachi Energy India Q4FY26 Results
âŞď¸ Revenue âš2,754.05 Cr (+46.2% YoY)
âŞď¸ Net Profit âš330.46 Cr (+79.7% YoY) | 109 |
| 16 |  Sin texto... | 110 |
| 17 | 1. Attack Iran
2. Stocks fall
3. Buy low
4. Announce a "deal"
5. Stocks rise
6. Sell high
How many times will this happen before it doesn't work anymore | 109 |
| 18 |  Tofay FII DII Activity
FII Sold 1082 CR
DII Buy 5341 CR | 127 |
| 19 | ⥠SUZLON LAYS OUT AMBITIOUS 5-YEAR EXPANSION PLAN
⢠The company is targeting a revenue CAGR of more than 25% over the next five years
⢠Suzlon aims to retain a market share of over 40% in India's wind energy sector
⢠Co-Development (Co-Dev) contribution is expected to rise to 60%+ by FY31
⢠The company is targeting export order inflows of more than 3 GW to strengthen its international business
⢠Renewable Energy AUM portfolio is projected to cross 70 GW
⢠Key focus areas include a resilient supply chain, integrated end-to-end solutions and a multi-tech, multi-brand growth strategy | 109 |
| 20 | AUROBINDO PHARMA: CO US FDA CLASSIFIES EUGIA UNIT-III AS OAI AFTER INSPECTION WITH 11 OBSERVATIONS | 105 |
